RE:RE:RE:RE:RE:big boys accumulating for 5 dollars levelWealth2015, I think there may be a little bit of a misunderstanding here.
Pandora is absolutely right that this stock was in the "below 20 cent" range before it consolidated in 2015. You have to remember that when you look at a 5 or 10 year chart, the chart has been modified to reflect the new share structure after the 10 to 1 consolidation that took place in 2015.
This stock did in fact trade below 20 cents for quite some time. It also, historically, was higher (around 50 cents+).
HOWEVER, where they have been is not something the markets are going to punish them for. It is not an easy process to get new tech manufactured, tested in clinical trials, and through the FDA/Health Canada. It's very risky and expensive for small startup companies and investors know that. These guys have succeeded in running the gauntlet to get their approvals and developing a product with a large market... that's what the current value proposition is about.
I don't find Pandora's posts to be misleading or dishonest and I think there may be a misunderstanding with how you are thinking of SP versus how he is, that's all.